Double Medical Technology Inc.

SZSE:002901 Stock Report

Market Cap: CN¥12.8b

Double Medical Technology Past Earnings Performance

Past criteria checks 1/6

Double Medical Technology's earnings have been declining at an average annual rate of -32.1%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 3.9% per year. Double Medical Technology's return on equity is 7.1%, and it has net margins of 10.4%.

Key information

-32.1%

Earnings growth rate

-32.6%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate3.9%
Return on equity7.1%
Net Margin10.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

There Are Reasons To Feel Uneasy About Double Medical Technology's (SZSE:002901) Returns On Capital

Dec 18
There Are Reasons To Feel Uneasy About Double Medical Technology's (SZSE:002901) Returns On Capital

Market Participants Recognise Double Medical Technology Inc.'s (SZSE:002901) Revenues Pushing Shares 29% Higher

Oct 01
Market Participants Recognise Double Medical Technology Inc.'s (SZSE:002901) Revenues Pushing Shares 29% Higher

Is Double Medical Technology (SZSE:002901) A Risky Investment?

Sep 27
Is Double Medical Technology (SZSE:002901) A Risky Investment?

Capital Allocation Trends At Double Medical Technology (SZSE:002901) Aren't Ideal

Sep 05
Capital Allocation Trends At Double Medical Technology (SZSE:002901) Aren't Ideal

Double Medical Technology (SZSE:002901) Seems To Use Debt Quite Sensibly

Jun 19
Double Medical Technology (SZSE:002901) Seems To Use Debt Quite Sensibly

Investors Could Be Concerned With Double Medical Technology's (SZSE:002901) Returns On Capital

May 28
Investors Could Be Concerned With Double Medical Technology's (SZSE:002901) Returns On Capital

Revenue & Expenses Breakdown

How Double Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SZSE:002901 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,937201754308
30 Jun 241,748104717296
31 Mar 241,56962700282
31 Dec 231,53359690285
30 Sep 231,325-22655263
30 Jun 231,3566723280
31 Mar 231,39439755273
31 Dec 221,43493786257
30 Sep 221,924432878244
30 Jun 221,976536836203
31 Mar 222,050654804183
01 Jan 221,994673763167
30 Sep 211,782632674152
30 Jun 211,761658640139
31 Mar 211,732647618134
31 Dec 201,587606574128
30 Sep 201,497550572118
30 Jun 201,387522535113
31 Mar 201,270472502107
31 Dec 191,257465467100
30 Sep 191,09743136188
30 Jun 1996440427977
31 Mar 1983538620169
31 Dec 1877237116765
30 Sep 1869836814459
30 Jun 1867033911084
31 Mar 1862030810967
31 Dec 1759429610954
30 Sep 1756026111240
31 Dec 164632191310
31 Dec 15392189970
31 Dec 14299139760

Quality Earnings: 002901 has a large one-off gain of CN¥47.5M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 002901 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 002901's earnings have declined by 32.1% per year over the past 5 years.

Accelerating Growth: 002901 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 002901 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).

Return on Equity

High ROE: 002901's Return on Equity (7.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 20:44
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Double Medical Technology Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.
Shuo SongCitic Securities Co., Ltd.
Yuan Yuan SunIndustrial Securities Co. Ltd.